Patents by Inventor Maria KONTARIDIS

Maria KONTARIDIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190000801
    Abstract: Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
    Type: Application
    Filed: September 10, 2018
    Publication date: January 3, 2019
    Inventors: Zhong-Yin ZHANG, Maria KONTARIDIS, Li-Fan ZENG, Jianxun WANG
  • Patent number: 10092543
    Abstract: Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: October 9, 2018
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Zhong-Yin Zhang, Maria Kontaridis, Li-Fan Zeng, Jianxun Wang
  • Publication number: 20180071252
    Abstract: Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
    Type: Application
    Filed: November 15, 2017
    Publication date: March 15, 2018
    Inventors: Zhong-Yin ZHANG, Maria KONTARIDIS, Li-Fan ZENG, Jianxun WANG
  • Patent number: 9844535
    Abstract: Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
    Type: Grant
    Filed: July 2, 2014
    Date of Patent: December 19, 2017
    Assignee: Indiana University Research and Technology Corporation
    Inventors: Zhong-Yin Zhang, Maria Kontaridis, Li-Fan Zeng, Jianxun Wang
  • Publication number: 20160374988
    Abstract: Methods are disclosed herein for administering a oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor for treating autoimmune and/or glomerulonephritis-associated diseases, and in particular, Systemic Lupus Erythematosus (SLE).
    Type: Application
    Filed: July 2, 2014
    Publication date: December 29, 2016
    Inventors: Zhong-Yin ZHANG, Maria KONTARIDIS, Li-Fan ZENG, Jianxun WANG